Knee osteoarthritis is the most common articular disease. In fact, osteoarthritis, in general, is a major public health concern not just here in the United States, but worldwide. As such, finding the most effective and safest treatment option available is of the utmost importance, especially as it pertains to the longevity of its impacts. To that end, a recent study published in the National Library of Medicine compared the effectiveness of triple injection Platelet Rich Plasma (PRP) treatments in adult knee osteoarthritis patients at one- and two-year intervals.

PRP is an advanced biocellular therapy from a patient’s own blood that regulates inflammation, stimulates repair, and promotes remodeling of damaged tissues. The premise behind utilizing PRP for orthopedic therapies is based on its abundant growth factors and proteins. In concentrating the number of platelets by volume and then administering them through precision injections directly into the injury site, physicians can help promote the healing process across a variety of tissues.